Rindex obtains license for AF prediction technology

05/1/2013 | MedCityNews.com

Rindex Medical has gained exclusive license from the Cleveland Clinic to develop the A-50 AF Prediction System, a tool that doctors can use to predict a patient's risk for atrial fibrillation after cardiac surgery. The Redwood City, Calif.-based startup has a working prototype of the device and is preparing to apply for 510(k) clearance.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT